Yahoo
HKSE - Delayed Quote HKD

Ocumension Therapeutics (1477.HK)

4.790 +0.180 (+3.90%)
At close: October 30 at 4:08:06 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
934,034
804,352
417,307
246,367
158,957
Cost of Revenue
493,254
443,430
192,242
102,002
56,041
Gross Profit
440,780
360,922
225,065
144,365
102,916
Operating Expense
560,765
517,431
529,142
545,705
551,141
Operating Income
-119,985
-156,509
-304,077
-401,340
-448,225
Net Non Operating Interest Income Expense
-903
3,951
20,056
20,595
26,428
Pretax Income
-124,791
-158,470
-267,257
-379,480
-402,229
Tax Provision
725
350
1,017
307
414
Net Income Common Stockholders
-125,516
-158,820
-268,274
-379,787
-402,643
Diluted NI Available to Com Stockholders
-125,516
-158,820
-268,274
-379,787
-402,643
Basic EPS
-0.15
-0.20
-0.39
-0.59
-0.64
Diluted EPS
-0.15
-0.20
-0.39
-0.59
-0.64
Basic Average Shares
794,431.588
791,198.269
687,882.051
643,706.780
632,531.914
Diluted Average Shares
794,431.588
791,198.269
687,882.051
643,706.780
632,531.914
Total Expenses
1,054,019
960,861
721,384
647,707
607,182
Net Income from Continuing & Discontinued Operation
-125,516
-158,820
-268,274
-379,787
-402,643
Normalized Income
-128,042
-160,780.500
-267,544.250
-382,775.750
-400,238.500
Interest Income
3,579
6,396
22,219
21,920
28,221
Interest Expense
4,482
2,445
2,163
1,325
1,793
Net Interest Income
-903
3,951
20,056
20,595
26,428
EBIT
-120,309
-156,025
-265,094
-378,155
-400,436
EBITDA
30,728
-12,291
-176,480
-320,619
-359,978
Reconciled Cost of Revenue
493,254
443,430
192,242
102,002
56,041
Reconciled Depreciation
151,037
143,734
88,614
57,536
40,458
Net Income from Continuing Operation Net Minority Interest
-125,516
-158,820
-268,274
-379,787
-402,643
Total Unusual Items Excluding Goodwill
3,368
2,614
-973
3,985
-3,206
Total Unusual Items
3,368
2,614
-973
3,985
-3,206
Normalized EBITDA
27,360
-14,905
-175,507
-324,604
-356,772
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
842
653.500
-243.250
996.250
-801.500
12/31/2022 - 7/10/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: